Artificial intelligence company Berg selected to help analyze genomic data of 100,000 U.K. citizens

Genomics England has hired Boston biotech Berg to help it accomplish its mission to sequence 100,000 genomes. Berg uses artificial intelligence "to look at patterns in the data to find areas in the biology that are fingerprints" of disease, said its co-founder and president, Niven Narain. The company's supercomputer, known as Betsy, studies the inside of cells, including their proteins and lipids. Berg has already partnered with Big Pharmas Roche ($RHHBY), Biogen ($BIIB), AstraZeneca ($AZN) and GlaxoSmithKline ($GSK). Genomics England is part of the U.K.'s federal Department of Health. More

Suggested Articles

The FDA will be working with government and public-private partners to distribute and evaluate 3D designs and models.

The FDA issued a wide-ranging emergency policy allowing alternative devices to be used as potentially lifesaving ventilators amid new shortages.

Hospitals in the New York City area are turning to a private distributor to airlift millions of protective masks out of China.